Premarin and Prempro
Information on Hormone Replacement Therapy - Causes Breast Cancer Risk.
Health risk to women halts hormone
study
BYLINE: PATRICIA GUTHRIE; Staff
DATE: July 9, 2002
PUBLICATION: Atlanta Journal-Constitution, The (GA)
EDITION: Home; The Atlanta Journal-Constitution
SECTION: News
PAGE: A1
Researchers abruptly halted a major federal study of hormone
replacement therapy -- used by tens of millions of American women --
because the drugs create what they consider an unacceptable risk for
breast cancer, heart disease, strokes and blood clots.
The study found women taking a combination of estrogen and progestin are
at increased risks that outweigh the benefits of the hormones, which
were found to reduce the risks of colon cancer and hip fractures.
|
 |
Diosgenin cream ingredients
| Benefits diosgenin cream |
How to use diosgenin cream. |
Return to Eden Diosgenin (nicknamed Progesterone) Cream.
Sorry - Product Discontinued
NEW!! NEW!!! BIG DRUG COMPANIES
USING THE FEDERAL TRADE COMMISSION IN AN ATTEMPT TO DESTROY COMPETITION FROM
NATURAL HORMONE REPLACEMENT THERAPIES!!!
Do you remember our newsletter
last year detailing how Wyeth Pharmaceuticals was attempting to stop
compounding pharmacists from prescribing natural progesterone (diosgenin)
after their profits fell by more than 57% from $2.07 billion in 2003 to
$800 million in 2004 (after the WHI study had to be stopped)?
Well, now they have gone after
centers like ours making complaints to the Federal Trade Commission
(FTC). The FTC's position backed by the big pharmaceutical companies is
that Dr. John Lee, M.D.'s studies were not scientific and did not rise to
the standard of FDA and National Institutes of Health studies, and that
our claims about natural progesterone are false, unfair, deceptive,
misleading advertising in violation of the law..
(Please read
what Dr. Helen Pensanti M.D. has to say about this. Read on to how the study
was conducted.)
This is an attempt to force women into taking
unsafe proven cancer causing synthetic hormones using
your tax dollar to harass natural hormone suppliers. We here at the Women's
Menopause Health Center refuse to take away your choice of a healthy
alternative to Premarin, Prempro and the other dangerous drugs. We are
taking a stand against this heavy handed attempt to destroy competition. We
are going to fight for your choice of a healthy way to get through menopause
comfortably and safely.
(Ed. note: This was from our newsletter last year. The
continued harassment by the FTC has caused us to discontinue our wonderful
product. DO NOT be forced
into taking something that can kill you. You may purchase safe
progesterone cream at your local health food store, or find it a lot less
expensively on line at places like ebay and yahoo stores.
Do not let these heavy handed tactics destroy your health!)
Return to Eden Chemical
Preservative FREE
Natural Progesterone Cream.
-
ALL NATURAL INGREDIENTS -
ARTIFICIAL AND CHEMICAL PRESERVATIVE FREE!
-
HIGHEST QUALITY NATURAL
INGREDIENTS USP PROGESTERONE CREAM ON MARKET TODAY.
-
500 MG/OZ USP PROGESTERONE, 100% PHARMACEUTICAL GRADE.
1-
4oz jar
Return to Eden Progesterone Cream
MSRP $26.99 $19.95
2- 4oz jars
Return to Eden Progesterone Cream
$35.95 |
Findings from the study, called the Women's Health Initiative, had not
been expected until 2008. But when evidence of the risks started
accumulating after five years, a review panel ordered the clinical trial
stopped -- something rarely done in medical studies.
(For WHI press release,
click here.)
"The bottom line is that estrogen plus progestin is not a viable option
to prevent chronic disease," said Dr. Gerardo Heiss, epidemiology
professor at the University of North Carolina at Chapel Hill School of
Public Health, who was on the study steering committee.
A hastily called news conference to discuss the findings is scheduled
for this morning in Washington and at numerous participating academic
centers, including Emory University.
The study is being released early on the Journal of the American Medical
Association Web site (www.jama.com) before appearing in print July 17.
In the JAMA article, researchers noted: "Given these results, we
recommend that clinicians stop prescribing this combination for
long-term use."
The study involved 16,608 postmenopausal women, 50-79 years old, who had
not had hysterectomies.
At Emory University, 286 metro Atlanta women were involved in the study,
a spokeswoman said.
Hormone replacement therapy is the second most frequently prescribed
drug regimen in America: 68 million prescriptions were written in 2000
for the two most popular forms, Premarin and Prempro. It has been
prescribed for almost 60 years.
The trial was stopped early "because of a 26 percent increased risk for
breast cancer and also a lack of overall benefit," Heiss said. "As soon
as the increased risk for breast cancer was established, the independent
data and safety monitoring board halted the study."
Experts advised women to consult their physician to discuss risks and
benefits before stopping hormone therapy.
The drug relieves menopausal symptoms, such as hot flashes, night sweats
and inability to concentrate. It is also prescribed in postmenopausal
women for protection against heart disease and osteoporosis, which
previous studies indicated it might provide.
Many studies in recent years have attempted to quantify the risks and
benefits of hormone replacement therapy, such as the increased incidence
of breast cancer or heart disease, or the reduced risk of osteoporosis
among women who take HRT. But past research has typically examined
various risks and benefits in isolation.
The latest study is believed to be the largest and most comprehensive to
examine and quantify all known risks and benefits and lay them out side
by side.
Although researchers advised doctors to stop prescribing HRT, they also
emphasized that the risk of harm to an individual woman is "very small."
Among 10,000 women taking the estrogen/progestin combination,
researchers estimated that there would be seven more cases of coronary
events, eight more breast cancers, eight more strokes and eight more
blood clots -- but six fewer colorectal cancers and five fewer hip
fractures -- than they would expect to find in women who don't take the
drugs.
Women in the study were divided into two groups -- those who took the
hormones and those who took a placebo. Scientists compared health
outcomes between the groups; the women were not told to which group they
were assigned.
Another part of the study involved 11,000 women who had undergone
hysterectomies and were taking only estrogen. That study has not been
stopped because no adverse effects have been found, researchers said.
The study did not address the short-term risks and benefits of hormones
given only for the treatment of menopausal symptoms.
Dr. Rogsbert Phillips, an Atlanta breast cancer specialist, said the
findings were not that surprising, given past research that raised
questions about the risks of HRT. The breast cancer/hormone replacement
connection weighs heavily on doctors when they are assessing whether to
place a woman on hormone replacement therapy, she said.
" It's no question that we feel that HRT plays a role in development of
breast cancer, and as we continue to research, we'll find out how much,"
Phillips said.
The doctor said she rarely prescribed HRT for more than five years.
However, she will make exceptions, she said, even for women who have
experienced breast cancer.
"I had one patient who was a mathematician and she said she just
couldn't think straight when she went off hormone replacement therapy.
She was a 20-year breast cancer survivor," Phillips said. "But I put her
back on them.
"There are some women who really, truly need it to manage these kinds of
menopausal symptoms. Hormones can greatly affect a woman's equilibrium."